Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Buggisch · SciRah

Researcher profile · Semantic Scholar

P. Buggisch

Share profile

P. Buggisch — researcher profile on SciRah

h-index: 41
Works: 346
Citations: 12K

Most-cited papers

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
M. Bourlière, S. Gordon, S. Flamm, C. Cooper +28 more
2017New England Journal of Medicine635 citations
Semantic Scholar
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
David E. J. Jones, P. Boudes, M. Swain, C. Bowlus +32 more
2017The Lancet Gastroenterology and Hepatology166 citations Open access
Semantic Scholar
Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection
P. Marcellin, D. Wong, W. Sievert, P. Buggisch +13 more
2019Liver international (Print)135 citations Open access
Semantic Scholar
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
J. Dietz, S. Susser, J. Vermehren, K. Peiffer +21 more
2017Gastroenterology133 citations
Semantic Scholar
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection
K. Kowdley, Vinay Sundaram, C. Jeon, K. Qureshi +9 more
2017Hepatology130 citations Open access
Semantic Scholar
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
F. van Bömmel, K. Stein, R. Heyne, J. Petersen +25 more
2023Journal of Hepatology92 citations Open access
Semantic Scholar
Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?
S. Christensen, P. Buggisch, S. Mauss, K. Böker +7 more
2018Addiction80 citations
Semantic Scholar
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.
C. Dietz-Fricke, F. Tacke, C. Zöllner, M. Demir +38 more
2023JHEP Reports69 citations Open access
Semantic Scholar
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
P. Buggisch, J. Vermehren, S. Mauss, R. Günther +10 more
2017Journal of Hepatology56 citations
Semantic Scholar
Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
T. Welzel, H. Hinrichsen, C. Sarrazin, P. Buggisch +18 more
2017Journal of Viral Hepatitis50 citations
Semantic Scholar
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials
F. Tacke, Rainer Günther, P. Buggisch, H. Klinker +8 more
2017Liver international (Print)41 citations
Semantic Scholar
Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe
P. Cacoub, P. Buggisch, José A. Carrión, G. S. Cooke +3 more
2018Journal of Viral Hepatitis33 citations Open access
Semantic Scholar
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
P. Buggisch, K. Wursthorn, A. Stoehr, P. Atanasov +4 more
2019PLoS ONE32 citations Open access
Semantic Scholar
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs
F. Tacke, K. Boeker, H. Klinker, R. Heyne +8 more
2020Liver international (Print)29 citations
Semantic Scholar
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting
C. Höner zu Siederdissen, P. Buggisch, K. Böker, E. Schott +8 more
2018United European Gastroenterology journal25 citations Open access
Semantic Scholar
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care
W. Hofmann, P. Buggisch, L. Schubert, N. Dikopoulos +13 more
2020JHEP Reports24 citations Open access
Semantic Scholar
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
J. Dietz, B. Müllhaupt, P. Buggisch, Christiana Graf +18 more
2022Journal of Hepatology21 citations
Semantic Scholar
Management of hepatic encephalopathy in Germany: a survey among physicians
C. Labenz, C. Adarkwah, M. Wörns, S. Miehlke +5 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology21 citations
Semantic Scholar
Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
F. van Bömmel, K. Stein, R. Heyne, H. Möller +30 more
2020Journal of Hepatology20 citations Open access
Semantic Scholar
Deutsches Hepatitis C-Register (DHC-R) – eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs)
D. Hüppe, Y. Serfert, P. Buggisch, S. Mauss +12 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology20 citations
Semantic Scholar
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
J. Dietz, U. Spengler, B. Müllhaupt, J. Schulze zur Wiesch +303 more
2019Clinical Gastroenterology and Hepatology20 citations Open access
Semantic Scholar
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients
B. Maasoumy, P. Buggisch, S. Mauss, K. Boeker +8 more
2018Liver international (Print)19 citations
Semantic Scholar
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry
F. Tacke, H. Klinker, K. Boeker, U. Merle +8 more
2022Hepatology Communications16 citations Open access
Semantic Scholar
Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
J. Dietz, O. Kalinina, J. Vermehren, K. Peiffer +21 more
2020Journal of Viral Hepatitis15 citations Open access
Semantic Scholar
Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study
M. Gabriel, G. Kircheis, S. Hardtke, D. Markwardt +11 more
2020European Journal of Gastroenterology and Hepathology14 citations
Semantic Scholar
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R)
S. Christensen, P. Buggisch, S. Mauss, K. Böker +7 more
2019Substance Abuse: Research and Treatment14 citations Open access
Semantic Scholar
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment
V. Knop, W. Hofmann, P. Buggisch, H. Klinker +9 more
2018Journal of Viral Hepatitis13 citations
Semantic Scholar
Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry
M. Rau, P. Buggisch, S. Mauss, K. Boeker +5 more
2022PLoS ONE11 citations Open access
Semantic Scholar
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease
Wan-Long Chuang, Tsung-Hui Hu, P. Buggisch, C. Moreno +13 more
2021American Journal of Gastroenterology11 citations Open access
Semantic Scholar
Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries
P. Ferenci, S. Bourgeois, P. Buggisch, S. Norris +10 more
2019Journal of Viral Hepatitis11 citations Open access
Semantic Scholar
[Diagnostic and prognostic significance of α-fetoprotein in hepatocellular carcinoma].
Jendrik Becker-Assmann, M. Fard-Aghaie, A. Kantas, G. Makridis +7 more
2020Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen10 citations
Semantic Scholar
Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany – First data from the German NAFLD-Registry
Andreas Geier, M. Rau, A. Pathil-Warth, M. R. von der Ohe +12 more
2022Zeitschrift für Gastroenterologie - German Journal of Gastroenterology9 citations
Semantic Scholar
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study
P. Buggisch, H. Heiken, S. Mauss, B. Weber +9 more
2021PLoS ONE9 citations Open access
Semantic Scholar
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy – data from the German hepatitis C registry (DHC-R)
A. Schmitt, R. Günther, S. Mauss, K. Boeker +11 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology9 citations
Semantic Scholar
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)
D. Hüppe, A. Stoehr, P. Buggisch, S. Mauss +6 more
2021Journal of Viral Hepatitis8 citations Open access
Semantic Scholar
Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study
C. Levy, C. Bowlus, G. Neff, M. Swain +42 more
2020Journal of Hepatology8 citations Open access
Semantic Scholar
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response
T. Asselah, C. Moreno, C. Sarrazin, M. Gschwantler +11 more
2017PLoS ONE8 citations Open access
Semantic Scholar
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
T. Zimmermann, D. Hueppe, S. Mauss, P. Buggisch +4 more
2016Journal of Gastrointestinal and Liver Diseases7 citations Open access
Semantic Scholar
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysis
Wan-Long Chuang, Tsung-Hui Hu, P. Buggisch, C. Moreno +12 more
2019Journal of Hepatology6 citations
Semantic Scholar
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection
Christiana Graf, A. Mondorf, V. Knop, K. Peiffer +19 more
2019Journal of Clinical Medicine6 citations Open access
Semantic Scholar
JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1
S. Zeuzem, S. Bourgeois, S. Greenbloom, M. Buti +17 more
2019Hepatology6 citations Open access
Semantic Scholar
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
J. Wiegand, P. Buggisch, S. Mauss, K. Boeker +9 more
2019European Journal of Gastroenterology and Hepathology6 citations
Semantic Scholar
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection
F. Zoulim, C. Moreno, Samuel S. Lee, P. Buggisch +8 more
2018Virology Journal6 citations Open access
Semantic Scholar
Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
Kathrin Krüger, S. Rossol, C. Krauth, P. Buggisch +6 more
2021Zeitschrift für Gastroenterologie - German Journal of Gastroenterology5 citations Open access
Semantic Scholar
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
Susanne Sarkar, J. Kemper, R. Sarkar, Loni Brants +16 more
2021Journal of Affective Disorders5 citations
Semantic Scholar
Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)
K. Deterding, S. Mauss, A. Pathil, P. Buggisch +13 more
20175 citations
Semantic Scholar
Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany
D. Hüppe, P. Buggisch, S. Christensen, H. Heiken +5 more
2016Zeitschrift für Gastroenterologie - German Journal of Gastroenterology5 citations
Semantic Scholar
Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Wks in Genotype 1 (GT1) Treatment-Naïve Non-Cirrhotic Patients with HCV Viral Load <6 Million IU/mL (6M); Acomparative Analysis of the Phase-3 ION-3 Data to Real World Effectiveness
P. Buggisch, J. Peterson, S. Mauss, K. Kowdley +10 more
20165 citations
Semantic Scholar
Treatment efficacy and safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12- and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study
G. Hirschfield, P. Boudes, C. Bowlus, N. Gitlin +30 more
20184 citations
Semantic Scholar
Efficacy and safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis: 52-week analysis of an ongoing international, randomized, dose ranging phase 2 study.
C. Bowlus, G. Neff, R. Aspinall, M. Galamboš +38 more
20184 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Mauss×22
Invite
S. Mauss — researcher profile on SciRah
T. Berg×18
Invite
T. Berg — researcher profile on SciRah
S. Zeuzem×16
Invite
S. Zeuzem — researcher profile on SciRah
H. Klinker×16
Invite
H. Klinker — researcher profile on SciRah

×13

Invite

D. Hüppe — researcher profile on SciRah

C. Sarrazin×13

Invite

C. Sarrazin — researcher profile on SciRah

H. Wedemeyer×13

Invite

H. Wedemeyer — researcher profile on SciRah

Invite

M. Manns — researcher profile on SciRah

H. Hinrichsen×8

Invite

H. Hinrichsen — researcher profile on SciRah

Invite

E. Schott — researcher profile on SciRah

J. Vermehren×7

Invite

J. Vermehren — researcher profile on SciRah

Invite

C. Berg — researcher profile on SciRah